MIMEDX to Participate in Upcoming Investor Conferences

MDXG 12.04.2024

Full Press ReleaseSEC FilingsOur MDXG Tweets

About Gravity Analytica

Recent News

  • 12.17.2024 - MIMEDX Files Patent Infringement Lawsuit Against Surgenex
  • 12.04.2024 - MIMEDX to Participate in Upcoming Investor Conferences
  • 11.18.2024 - Stifel Healthcare Conference 2024

Recent Filings

  • 01.14.2025 - EX-99.1 EX-99.1
  • 01.14.2025 - 8-K Current report
  • 12.13.2024 - 4 Statement of changes in beneficial ownership of securities

MARIETTA, Ga., Dec. 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

Mizuho Health Care ConferenceWednesday, December 11, 20241:1 sessions | New York, NY

Northland Growth ConferenceThursday, December 12, 20241:1 sessions | Virtual

Stifel MedTech West Coast Bus TourThursday, December 12, 20241:1 sessions | Palo Alto, CA

Investors interested in meeting with senior management at these events may contact their respective Mizuho, Northland Capital or Stifel representative.

About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visitwww.mimedx.com.

Contact:

Matt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com